Shire PLC (SHPG)

172.67
3.70 2.10
NASDAQ : Health Care
Prev Close 176.39
Open 175.45
Day Low/High 170.90 / 175.73
52 Wk Low/High 147.60 / 270.63
Volume 940.77K
Avg Volume 1.31M
Exchange NASDAQ
Shares Outstanding 301.06M
Market Cap 52.63B
EPS 6.60
P/E Ratio 47.50
Div & Yield 0.28 (0.20%)

Latest News

Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan

Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan

The U.S. Food and Drug Administration turned down Amicus' request to seek accelerated approval for Galafold based on an existing kidney biomarker data.

Actelion Soars as Johnson & Johnson 'Makes Takeover Proposal'

Actelion Soars as Johnson & Johnson 'Makes Takeover Proposal'

The Swiss biotech was last year reported to be a target of Shire.

Shire To Establish Rare Disease Innovation Hub In Cambridge, Mass.

Shire To Establish Rare Disease Innovation Hub In Cambridge, Mass.

Company to expand into 500 Kendall Street and create a 550,000-square-foot campus focused on rare diseases and highly specialized conditions

Six Thoughts on President Trump and the Durability of the Biotech Stock Rally

Six Thoughts on President Trump and the Durability of the Biotech Stock Rally

Investors have convinced themselves that President Donald Trump is going to make drug stocks great again. Will it last?

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

Stock futures are tumbling Wednesday but are well off their lows as Republican Donald Trump is elected the next president of the United States in a surprising victory.

European Drug Companies Get an Injection From Trump Victory

European Drug Companies Get an Injection From Trump Victory

The threat of a government clampdown on drug prices is off the table with Clinton's defeat, while wider support for defensive stocks helped push pharmaceuticals higher.

Stocks Slip in Uncertain Start to November Amid Election Uncertainty

Stocks Slip in Uncertain Start to November Amid Election Uncertainty

Stocks slip on Tuesday in a weaker start to November as uncertainty over the upcoming presidential election weighs on Wall Street.

Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge

Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge

Pfizer, Bayer, Shire are among rivals bracing for Roche's ACE910.

Stocks Suffer Bad Start to November as Election Uncertainty Overwhelms

Stocks Suffer Bad Start to November as Election Uncertainty Overwhelms

Wall Street suffered a dismal start to the month on Tuesday as conflicting polls bred uncertainty over the upcoming presidential election.

Stocks Extend Losses Amid Election Uncertainty, Crude Falls

Stocks Extend Losses Amid Election Uncertainty, Crude Falls

Stocks extend losses by mid-afternoon Tuesday in a weaker start to November as uncertainty over the upcoming presidential election weighs on Wall Street.

European Stock Markets Fall as Bond Selloff Hits Dividend Yielders Across the Board

European Stock Markets Fall as Bond Selloff Hits Dividend Yielders Across the Board

The German DAX leads the way as all major European indices close in the red on Tuesday.

Week Ahead: Fed Meeting, Jobs Report Paint Clearer Picture for Rate Hike Chances

Week Ahead: Fed Meeting, Jobs Report Paint Clearer Picture for Rate Hike Chances

The Federal Reserve will again convene in the coming week to discuss monetary policy, but investors will instead focus on what it may mean for a rate hike in December.

Results From Shire's Phase 2 Study Of Maribavir Showed Activity Against CMV Infection In Patients Undergoing Transplant

Results From Shire's Phase 2 Study Of Maribavir Showed Activity Against CMV Infection In Patients Undergoing Transplant

Data support progressing with Phase 3 clinical development program

Pardon Me, but I Have a Few Things to Say... Trump, Bernie, Radius, Ariad

Pardon Me, but I Have a Few Things to Say... Trump, Bernie, Radius, Ariad

Why Trump is killing biotech stocks, the Shire-for-Radius rumor makes no sense and Bernie Sanders gets a tweeting lesson.

Multimedia Assets Available: Modern Technology And A Multi-Screen Lifestyle Viewed As Important Factors In Rising Prevalence Of Dry Eye Disease

Multimedia Assets Available: Modern Technology And A Multi-Screen Lifestyle Viewed As Important Factors In Rising Prevalence Of Dry Eye Disease

-- Results from the National Eye C.A.R.E. Survey reinforce potential link between tech-dependency and growing risk of dry eye disease

Supernus Offers Super Small-Cap Potential

Supernus Offers Super Small-Cap Potential

Given the biotech's growth prospects and pipeline assets, its shares seem greatly undervalued.

Baxter Needs a Growth Injection From Management

Baxter Needs a Growth Injection From Management

Baxter reports its third-quarter earnings Tuesday.